HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for ...
Fintel reports that on October 31, 2025, Cantor Fitzgerald maintained coverage of Cabaletta Bio (NasdaqGS:CABA) with a Overweight recommendation. As of October 30, 2025, the average one-year price ...
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Korro Bio (NasdaqCM:KRRO) with a Overweight recommendation. As of April 24, 2025, the average one-year price target for ...
Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Gossamer Bio in a report issued on Monday, March 24th. Cantor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback